報價延遲最少15分鐘:2025/01/21 08:44 EST
|
|
|
|
|
||||||||||||
|
|
|
|
|
-- 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-0.91/-0.47
|
|
企業價值
737.52M
|
| 資產負債 |
|
每股賬面淨值
3.93
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
138.89M
|
|
每股收益
3.15
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/01/21 08:44 EST
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma. |